Search PubMed⌕ Search

Biomedical subjects

S Harmon

Publications and source records attributed to S Harmon.

27 records · Page 2Linked to original sources
PubMed1991

Analysis of the structure and expression of the human dopamine D2A receptor gene.

In order to study the possible involvement of dopamine receptors in the pathophysiology of various neurological and psychiatric disorders, we have isolated the human D2A gene. Like the rat D2A gene, the human gene contains at least eight exons and spans at least 52 kb. Exons 2-8 are clustered within 14 kb of genome. Exon 1 is separated from exon 2 by at least 38 kb. We and others have shown that alternative utilization of exon 6 gives rise to alternative D2A transcripts. Despite the extreme size of intron 1, no alternative transcription between exons 1 and 2 can be detected in basal ganglia and pituitary using polymerase chain reaction analysis. The relative abundance and tissue distribution of the alternative D2A transcripts were examined in 18 human brain regions. The relative expression of the transcripts varied by at least 70-fold across the brain regions surveyed. As expected, high levels of transcripts were detected in caudate, putamen, and pituitary. Moderate levels were detected in regions of catecholamine-containing cell bodies and in the amygdala. In contrast to the rat brain, very low levels of transcripts were detected in cortical regions.

Base Sequence↗
PubMed1990

Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues.

We have previously shown that the mRNA for human tyrosine hydroxylase (TH) exists in one of 4 forms as a result of alternative splicing of intron 1. In order to determine the tissue-specific expression of the multiple human transcripts we have utilized specifically primed polymerase chain reactions (PCR) in combination with reverse-transcribed RNA. Using PCR analysis we determined that many human neuronal tissues express all 4 forms of human TH (hTH-1-4); however, hTH-3 and -4 are generally expressed at less than 1% of the other two. Of all tissues examined, only pancreatic beta-islet cells expressed a single form of human TH mRNA (hTH-2). The mRNA for rat TH is present in only one form, the equivalent of hTH-1. Since we have shown that the human genes for TH and insulin are only 2.7 kb apart and several groups have reported insulin-like expression in neuronal tissues, we looked for insulin transcription in the same central and peripheral nervous system samples. Insulin mRNA was not present within the limits of detection.

Animals↗
PubMedDate not supplied

Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children.

Eighty-one patients ages one month to 14 years with meningitis were randomized to receive either sulbactam (50 mg/kg per day) and ampicillin (400 mg/kg per day; 41 patients) or chloramphenicol and ampicillin (40 patients). The groups were comparable in terms of sex and degree of illness; however, more patients treated with chloramphenicol/ampicillin than patients treated with sulbactam/ampicillin were younger than 12 months of age (78% vs. 56%). Pathogens were isolated from the cerebrospinal fluid (CSF) of 65 (80%) of the 81 patients. In the sulbactam/ampicillin group, there were 18 Haemophilus influenzae isolates (one resistant to ampicillin), five Streptococcus pneumoniae, five Neisseria meningitidis, one Klebsiella pneumoniae, one Pseudomonas aeruginosa, and one Listeria. In the chloramphenicol/ampicillin group, there were 19 H. influenzae isolates, 10 S. pneumoniae, three N. meningitidis, one Haemophilus parainfluenzae, and one Citrobacter. Of 63 patients with assessable CSF pathogens, one (3%) of 29 treated with sulbactam/ampicillin died (S. pneumoniae) and six (18%) of 34 treated with chloramphenicol/ampicillin died (two, H. influenzae; three, S. pneumoniae; and one, Citrobacter). Twelve percent in the sulbactam/ampicillin group and 18% in the chloramphenicol/ampicillin group had neurologic sequelae. No clinically significant reactions or toxicities were noted. Sulbactam/ampicillin was as effective as chloramphenicol/ampicillin in the treatment of meningitis.

Adolescent↗
PubMedDate not supplied

Developmental interactions of cells mutant for Strong's luxoid gene with normal cells in chimeric mice.

Mouse chimeras were made by fusing embryos from the albino BALB/cFo normal skeleton strain producing a slow variant isozyme of glucose phosphate isomerase (GPI) with embryos from the black pigmented SH strain carrying Strong's luxoid gene (symbol: 1st) for skeletal anomalies and producing a fast GPI variant. All chimeras were estimated to bALB/cFo mice to determine the mosaic status of their gonads. In addition, the quantitative proportions of BALB/cFo and SH cells in skin and limb muscles of chimeras were determined by visual estimation of the degree of coat pigmentation and by a serial dilution method applied to electrophoresis and GPI isozyme reaction of limb muscle homogenates. Skeletons of all chimeras and of representative samples of BALB/cFo and SH mice were examined and graded for expression of a number of normal and mutant skeletal characteristics. The most important conclusion of this study is that there was a definite quantitative effect on the development of skeletal characteristics exerted by the relative amount of BALB/ cFo and SH cells present in a chimera such that a structure could vary from normal to entirely mutant, depending on the proportion of each type of cell present.

Animals↗